Molecular Data Inc. American Depositary Shares
MKD was delisted on the 6th of September, 2022.
1 hedge funds and large institutions have $9K invested in Molecular Data Inc. American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$5.88K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $9K | +$5.88K | +210 | New |
|
MKD Hedge Fund Activity: Q2 2020 in Review
1 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Molecular Data Inc. American Depositary Shares (MKD) for Q2 2020, worth a combined $9K.
Buyers outnumbered sellers: 1 fund opened new MKD positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $5.88K.
- 1 institutional investor held Molecular Data Inc. American Depositary Shares (MKD) as of Q2 2020, up from 0 in Q1 2020.
- Funds reported $9K of Molecular Data Inc. American Depositary Shares stock for Q2 2020.
- 1 fund opened new Molecular Data Inc. American Depositary Shares positions in Q2 2020 and 0 closed out, a net change of +1 holder.
- The largest Molecular Data Inc. American Depositary Shares buyer in Q2 2020 was UBS Group, an estimated $5.88K added.
Based on aggregated 13F filings for Q2 2020.